Europe PMCopen access
Exploring the gut microbiome and metabolomic interactions of antimetabolite drugs to optimize therapy
Toxicity, Biomarker, intervention, efficacy, Gut Microbiota, Antimetabolite Drugs
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 4602
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.